Treatment
Genetics
New
CRISPR-Based Gene Editing Shows Promise in Targeting Triple-Negative Breast Cancer Cells
Nature Medicine, March 2026 | Dr. Sarah Chen, Dr. Michael Torres et al.
Researchers demonstrate a novel CRISPR-Cas9 approach that selectively targets cancer cells while leaving healthy tissue untouched. The study involved 200 patients across 15 clinical sites and showed a 65% reduction in tumor size within 8 weeks of treatment.
12.4k reads
48 annotations
15 min read